Swietlik, John F. http://orcid.org/0000-0002-7180-794X
Knott, Emily A.
Longo, Katherine C.
Zlevor, Annie M.
Zhang, Xiaofei
Laeseke, Paul F.
Reeder, Scott B.
Xu, Zhen
Lee, Fred T. Jr
Ziemlewicz, Timothy J.
Funding for this research was provided by:
Histosonics, Inc.
Article History
Received: 23 March 2022
Accepted: 19 August 2022
First Online: 12 September 2022
Declarations
:
: JS, EK, KL, AZ, XZ: None. PFL: Histosonics, Inc: stockholder and research support; Ethicon, Inc: paid consultant; Elucent Medical: paid consultant and stockholder; McGinley Orthopedic Innovations: stockholder; Siemens Medical: research support. SBR: Elucent Medical: stockholder; Reveal Pharmaceuticals: stockholder; Cellectar Biosciences: stockholder; HeartVista: stockholder. ZX: Histosonics, Inc: founder, stockholder, paid consultant, research support. FTL: Histosonics, Inc: Board of Directors, stockholder, research support; Medtronic Inc: patents, royalties; Ethicon, Inc: paid consultant. TZ: Histosonics, Inc: stockholder; Ethicon, Inc: paid consultant.
: For this type of study, consent for publication is not required.<b>Ethical Approval.</b>All applicable internation, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
: For this type of study, informed consent is not required.